维普中文期刊产品整合服务
132篇 您的检索式:作者名="Efthimiadis"
    题名 作者 年代 出处 被引量
1WJC 6~th Anniversary Special Issues(3):Cardiomyopathy Hypertrophic cardiomyopathy in 2013:Current speculations and future perspectives显示文摘Hypertrophic cardiomyopathy(HCM),the most variable cardiac disease in terms of phenotypic presentation and clinical outcome,represents the most common inherited cardiomyopathic process with an autosomal dominant trait of inheritance.To date,more than 1400 mutations of myofilament proteins associated with the disease have been identified,most of them 'private' ones.This striking allelic and locus heterogeneity of the disease certainly complicates the establishment of phenotype-genotype correlations.Additionally,topics pertaining to patients' everyday lives,such as sudden cardiac death(SCD)risk stratification and prevention,along with disease prognosis,are grossly related to the genetic variation of HCM.This review incorporates contemporary research findings and addresses major aspects of HCM,including preclinical diagnosis,genetic analysis,left ventricular outflow tract obstruction and SCD.More specifically,the spectrum of genetic analysis,the selection of the best method for obstruction alleviation and the need for a unique and accuratefactor for SCD risk stratification are only some of the controversial HCM issues discussed.Additionally,future perspectives concerning HCM and myocardial ischemia,as well as atrial fibrillation,are discussed.Rather than enumerating clinical studies and guidelines,challenging problems concerning the disease are critically appraised by this review,highlighting current speculations and recommending future directions.Georgios K Efthimiadis Efstathios D Pagourelias Thomas Gossios Thomas Zegkos 2014World Journal of Cardiology2014,6,2:9
2Conversion coatings of Mg-alloy AZ91D using trihexyl(tetradecyl) phosphonium bis(trifluoromethanesulfonyl)amide ionic liquid显示文摘This work reveals the performance of a trihexyl(tetradecyl)phosphonium bis(trifluoromethanesulfonyl)amide ([P6,6,6,14][NTf2]) ionic liquid (IL) conversion coating upon AZ91D. Such conversion coatings represent a novel avenue for chromate replacement. An optimization of coating performance was pursued by careful alloy pretreatment to generate a surface on which the coating performs best, as the AZ91 substrate is distinctly different from pure or dilute Mg alloys. The results reveal that a functional conversion coating can be achieved, retarding anodic dissolution kinetics, causing a significant decrease in corrosion rate. The coating efficacy is closely tied to the pretreatment performed, which dictates both the microstructural and electrochemical heterogeneity of the surface. The resulting coatings were found to contain MgxFx and phosphonium cation related components, the proportions of which were dependent on the pretreatment.HOWLETT P. C. GRAMET S. LIN J. EFTHIMIADIS J. CHEN X. B. BIRBILIS N. FORSYTH M. 2012Science China Chemistry2012,55,8:2
3Measuring airway inflammation in asthma:eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood 显示文摘Pizzichini E Pizzichini MM Efthimiadis A 1997J Allergy Clin Immunol1997,99,4:1
4Left ventrieular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy 显示文摘Efthimiadis GK Parcharidou DG Giannakoulas G 2009Am J Cardiol2009,104,5:1
5Methods of sputum proces- sing for cell counts,immunocytochemistry and in situ hybridisation 显示文摘Efthimiadis A Spanevello A Hamid Q 2002Eur Respir J Suppl2002,37,:1
6Left Ventricular Outflow Tract Obstruction as a Risk Factor for Sudden Cardiac Death in Hypertrophic Cardiomyopathy显示文摘Georgios K. Efthimiadis Despina G. Parcharidou Georgios Giannakoulas Efstathios D. Pagourelias Panagiotis Charalampidis Gregorios Savvopoulos Antonios Ziakas Haralambos Karvounis Ioannis H. Styliadis Georgios E. Parcharidis 2009The American Journal of Cardiology2009,,5:1
7Indices of airway inflam- mation in induced sputum :reproducibility and validity of cell and fluid- phase measurements显示文摘Pizzichini E Pizzichini MM Efthimiadis A 1996Am J Respir Crit Care Med1996,154,21:1
8显示文摘 Wong AG Efthimiadis A 1996Am J Respir Crit Care Med1996,153,2:1
9Indices of airway inflammation in induced sputum:reproducibility and validity of cell and fluid-phase measurements显示文摘PIZZICHINI E PIZZICHINI M M EFTHIMIADIS A 1996Am J Respir Crit Care Med1996,154,21:1
10Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements 显示文摘Pizzichini E Pizzichini MM Efthimiadis A 1996Am J Respir Crit Care Med1996,154,21:1
11Methods of sputum processing for cell counts,immunocytochemistry and in situ hybridisation显示文摘Efthimiadis A Spanevello A Haroid Q 2002Eur Respir J Suppl2002,37,:1
12Indices of airway inflammation in induced sputum: reproducibility and validity of cell fluid phase measurements显示文摘Pizzichini E Pizzichini MMM Efthimiadis A 1996Am J Respir Crit Care Med1996,154,3:1
13Risk factors of ischaemic heart disease and long-term outcome after coronary bypass surgery显示文摘Efthimiadis A Lefkos N Psirropoulos D 2001J Cardiovas Surg(Torino)2001,42,6:1
14Manometric and clinical evaluation of patients after low anterior resection for rectal cancer 显示文摘Efthimiadis C Basdanis G Zatagias A 2004Tech Coloproctol2004,8,1:1
15Induced sputum: time from expectoration to processing显示文摘Efthimiadis A Jayaram L Weston S 2002Eur Respir J2002,19,:1
16Rosuvaststin and cardiovascular diease :did the strongest statin hold the initial promises 显示文摘Efthimiadis 2008Apostolos Angi- ology2008,59,2:1
17显示文摘 Pizzichini MM Efthimiadis A 1996AmJ Respir Crit Care Med1996,154,21:1
18Indices of airway inflammation in induced sputum:reproducibility and validity of cell fluid phase measurements 显示文摘Pizzichini E Pizzichini M M Efthimiadis A et al 1996Am J Respir Crit Care Med1996,154,21:1
19Sputum CD34+IL-5Ralpha+ cells increase after allergen:evidence for insitu eosinophilo:poiesis显示文摘Dorman SC Efthimiadis A Babirad I 2004Am J Respir Crit Care Med2004,169,5:1
20Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease 显示文摘TAVRIDOU A EFTHIMIADIS A EFTHIMIADIS I 2006Eur J Clin Phaln2006,62,6:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费